Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Liver transplantation1521 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00020 | 35251901 | Australas J Ultrasound Med | Portal Venous Pulsatility Index as a predictor of fibrosis in patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A00058 | 35238782 | Turk J Gastroenterol | Evaluation of Magnetic Resonance Elastography and Transient Elastography for Liver Fibrosis and Steatosis Assessments in the Liver Transplant Setting. | 2022 | Details |
| A00074 | 35230042 | Swiss Med Wkly | Increasing prevalence of obesity and diabetes among patients evaluated for liver transplantation in a Swiss tertiary referral center: a 10-year retrospective analysis. | 2022 | Details |
| A00132 | 35212989 | Methods Mol Biol | Purification and Isolation of Hepatic Stellate Cells. | 2022 | Details |
| A00143 | 35211584 | World J Clin Cases | Nonalcoholic fatty liver disease shows significant sex dimorphism. | 2022 | Details |
| A00145 | 35208613 | Medicina (Kaunas) | Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy. | 2022 | Details |
| A00195 | 35190696 | Acta Pharmacol Sin | Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis. | 2022 | Details |
| A00216 | 35181565 | Clin Gastroenterol Hepatol | UNOS Down-staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies. | 2022 | Details |
| A00233 | 35173541 | Int J Biol Sci | The role of MLKL in Hepatic Ischemia-Reperfusion Injury of Alcoholic Steatotic Livers. | 2022 | Details |
| A00236 | 35172328 | J Clin Endocrinol Metab | Growth hormone and insulin-like growth factor I regulation of nonalcoholic fatty liver disease. | 2022 | Details |
| A00242 | 35170434 | Saudi J Gastroenterol | Saudi association for the study of liver diseases and transplantation position statement on the hepatology workforce in Saudi Arabia. | -- | Details |
| A00250 | 35165568 | Cureus | Efficacy of Lipid Ratios and Platelet Distribution Width for Assessment of Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease. | 2022 | Details |
| A00274 | 35157960 | J Hepatol | Hepatic lymphatic vascular system in health and disease. | 2022 | Details |
| A00298 | 35146945 | Hepatol Commun | A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00339 | 35129295 | Liver Int | Differential fuel utilization in liver transplant recipients and its relationship with non-alcoholic fatty liver disease. | 2022 | Details |
| A00371 | 35114889 | Organogenesis | Therapeutic Potential of HNF4α in End-stage Liver Disease. | 2021 | Details |
| A00379 | 35110952 | World J Gastroenterol | Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link. | 2022 | Details |
| A00407 | 35096933 | Front Nutr | Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation. | 2022 | Details |
| A00440 | 35083304 | Front Cardiovasc Med | Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis. | 2022 | Details |
| A00446 | 35080048 | J Gastroenterol Hepatol | Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease. | 2022 | Details |
| A00465 | 35070018 | World J Hepatol | Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study. | 2021 | Details |
| A00472 | 35068798 | J Clin Exp Hepatol | Diagnosis and Management of Cirrhotic Cardiomyopathy. | 2021 | Details |
| A00545 | 35051649 | Clin Gastroenterol Hepatol | Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study. | 2022 | Details |
| A00552 | 35048297 | J Gen Intern Med | The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care. | 2022 | Details |
| A00577 | 35042213 | Pathobiology | Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Immunohistochemical Assessment of Markers of Cancer Cell Metabolism. | 2022 | Details |
| A00610 | 35030194 | PLoS One | Mechanisms of liver injury in high fat sugar diet fed mice that lack hepatocyte X-box binding protein 1. | 2022 | Details |
| A00643 | 35016856 | Obes Res Clin Pract | High-priority liver transplantation and simultaneous sleeve gastrectomy in MELD 32 end-stage liver disease: a case report with long-term follow-up. | 2022 | Details |
| A00778 | 34970870 | Hepatol Commun | Fibrosis-4 Index as an Independent Predictor of Mortality and Liver-Related Outcomes in NAFLD. | 2021 | Details |
| A00783 | 34966854 | Hepatoma Res | Nonalcoholic fatty liver disease-related hepatocellular carcinoma growth rates and their clinical outcomes. | 2021 | Details |
| A00800 | 34962132 | Rev Esp Enferm Dig | Can NAFLD overwhelm the Spanish healthcare system in the years to come? | 2022 | Details |
| A00977 | 34912244 | Front Physiol | Translational Control in Liver Disease. | 2021 | Details |
| A00982 | 34910548 | Sci Transl Med | A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques. | 2021 | Details |
| A01073 | 34878418 | Curr Opin Anaesthesiol | Preoperative evaluation of geriatric patients undergoing liver transplantation. | 2022 | Details |
| A01077 | 34876018 | BMC Gastroenterol | Variations in TM6SF2, PCSK9 and PCSK7 genes and risk of hepatic steatosis after liver transplantation: a cross-sectional study. | 2021 | Details |
| A01088 | 34872045 | Clin Nutr | Τhe anthropometric and biochemical profile of pediatric non-alcoholic fatty liver disease: A systematic review and a meta-analysis. | 2021 | Details |
| A01112 | 34866847 | J Clin Exp Hepatol | Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis. | 2021 | Details |
| A01147 | 34855339 | FP Essent | Liver Disease: Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01217 | 34826302 | Am J Case Rep | A New Potential Strategy for Acute Non-Alcoholic Steatohepatitis (NASH). | 2021 | Details |
| A01228 | 34822057 | Hepatol Int | Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure. | 2021 | Details |
| A01274 | 34805582 | Transl Gastroenterol Hepatol | Narrative review of current and emerging pharmacological therapies for nonalcoholic steatohepatitis. | 2021 | Details |
| A01286 | 34802660 | Clin Liver Dis | Endoscopic Bariatric Interventions in Patients with Chronic Liver Disease. | 2021 | Details |
| A01333 | 34786172 | World J Hepatol | Liver and COVID-19: From care of patients with liver diseases to liver injury. | 2021 | Details |
| A01350 | 34778544 | Transplant Direct | Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. | 2021 | Details |
| A01367 | 34773291 | Transpl Int | A meta-analysis on the prevalence of chronic kidney disease in liver transplant candidates and its associated risk factors and outcomes. | 2021 | Details |
| A01395 | 34762106 | JAMA | Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis. | 2021 | Details |
| A01425 | 34753223 | Liver Transpl | Noninvasive Risk Stratification for Nonalcoholic Fatty Liver Disease Among Living Liver Donor Candidates: A Proposed Algorithm. | 2021 | Details |
| A01468 | 34736591 | Pediatr Clin North Am | Pediatric Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01475 | 34734369 | J Gastrointest Surg | The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases. | 2021 | Details |
| A01482 | 34730559 | Clin Transl Gastroenterol | Changing Trends of Cirrhotic and Noncirrhotic Hepatocellular Carcinoma in the Era of Directly-Acting Antiviral Agents. | 2021 | Details |
| A01511 | 34715296 | Free Radic Biol Med | Role of vitamin E in the treatment of non-alcoholic steatohepatitis. | 2021 | Details |
| A01527 | 34707687 | Therap Adv Gastroenterol | Safety of anti-TNF agents in patients with compensated cirrhosis: a case-control study. | 2021 | Details |
| A01536 | 34706656 | BMC Gastroenterol | Correlation between HDL2, HDL3 and serum ferritin levels with fatty liver and NAFLD activity score (NAS) in liver histology of organ donors. | 2021 | Details |
| A01561 | 34693238 | JHEP Rep | Non-invasive biomarkers of Fontan-associated liver disease. | 2021 | Details |
| A01653 | 34666156 | Clin Gastroenterol Hepatol | The Impact of NASH to Liver Transplantations With Hepatocellular Carcinoma in the United States. | 2021 | Details |
| A01746 | 34630100 | Front Pharmacol | CBD Alleviates Liver Injuries in Alcoholics With High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome-Pyroptosis Pathway. | 2021 | Details |
| A01838 | 34598315 | Immun Inflamm Dis | Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation. | 2021 | Details |
| A01849 | 34590386 | Pediatr Transplant | Hepatic macrosteatosis in the US pediatric deceased liver donor population. | 2021 | Details |
| A01911 | 34564931 | Liver Transpl | Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis. | 2021 | Details |
| A01913 | 34564441 | Metabolites | Lipid Profile and Hepatic Fat Content Measured by 1H MR Spectroscopy in Patients before and after Liver Transplantation. | 2021 | Details |
| A01943 | 34557660 | JHEP Rep | Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B. | 2021 | Details |
| A01952 | 34555422 | J Hepatol | NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options. | 2021 | Details |
| A01967 | 34549325 | Eur Radiol | Diagnostic performance of ultrasound attenuation imaging for assessing low-grade hepatic steatosis. | 2021 | Details |
| A01979 | 34543610 | Lancet | Liver cirrhosis. | 2021 | Details |
| A02107 | 34505423 | Endocrinol Diabetes Metab | Oxy210, a novel inhibitor of hedgehog and TGF-β signalling, ameliorates hepatic fibrosis and hypercholesterolemia in mice. | 2021 | Details |
| A02261 | 34444807 | Nutrients | Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut-Liver Axis. | 2021 | Details |
| A02266 | 34442328 | J Pers Med | Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection. | 2021 | Details |
| A02391 | 34391652 | J Cardiothorac Vasc Anesth | Management of Patients With Non-alcoholic Steatohepatitis Undergoing Liver Transplantation: Considerations for the Anesthesiologist. | 2021 | Details |
| A02405 | 34384674 | Asian J Surg | Non-alcoholic fatty liver disease and obesity among adult donors are major challenges to living-donor liver transplantation: A single-center experience. | 2021 | Details |
| A02519 | 34342335 | Ann Acad Med Singap | New-onset cardiovascular risk factors following liver transplantation: A cohort analysis in Singapore. | 2021 | Details |
| A02526 | 34341018 | BMJ Open Gastroenterol | Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosis. | 2021 | Details |
| A02608 | 34311133 | Clin Res Hepatol Gastroenterol | How will NAFLD change the liver transplant landscape in the 2020s? | 2021 | Details |
| A02611 | 34310738 | Hepatology | Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. | 2021 | Details |
| A02624 | 34305351 | J Clin Exp Hepatol | SARS-CoV-2 infection in Liver Transplant recipients - Immunosuppression is the silver lining? | 2021 | Details |
| A02653 | 34297426 | Hepatology | Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate-Activated Protein Kinase Signaling Pathway. | 2021 | Details |
| A02658 | 34294937 | Pathologica | Pathology of non-alcoholic fatty liver disease. | 2021 | Details |
| A02673 | 34289507 | Semin Liver Dis | Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities. | 2021 | Details |
| A02694 | 34280304 | Cochrane Database Syst Rev | Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis. | 2021 | Details |
| A02775 | 34248137 | Med Sci Monit | Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD). | 2021 | Details |
| A02780 | 34243194 | Semin Liver Dis | Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases. | 2021 | Details |
| A02791 | 34239263 | World J Gastroenterol | Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements. | 2021 | Details |
| A02815 | 34231659 | Arq Gastroenterol | PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS. | 2021 | Details |
| A02842 | 34221929 | J Clin Transl Hepatol | Nonalcoholic Fatty Liver Disease after Liver Transplant. | 2021 | Details |
| A02849 | 34219362 | Liver Int | The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study. | 2021 | Details |
| A02863 | 34212895 | Am J Gastroenterol | Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis. | 2021 | Details |
| A02884 | 34205986 | Med Sci (Basel) | Hepatocrinology. | 2021 | Details |
| A02898 | 34203178 | Int J Mol Sci | Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis. | 2021 | Details |
| A02914 | 34199535 | J Pers Med | Target Therapies for NASH/NAFLD: From the Molecular Aspect to the Pharmacological and Surgical Alternatives. | 2021 | Details |
| A03041 | 34155794 | Liver Int | New drugs for NASH. | 2021 | Details |
| A03042 | 34155792 | Liver Int | Natural history of NASH. | 2021 | Details |
| A03043 | 34155789 | Liver Int | COVID-19 and the liver - Lessons learned. | 2021 | Details |
| A03136 | 34118015 | Updates Surg | Liver transplantation and bariatric surgery: a new surgical reality: a systematic review of the best time for bariatric surgery. | 2021 | Details |
| A03142 | 34114650 | Cochrane Database Syst Rev | Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. | 2021 | Details |
| A03199 | 34092976 | World J Gastroenterol | COVID-19 in normal, diseased and transplanted liver. | 2021 | Details |
| A03203 | 34091049 | Clin Gastroenterol Hepatol | A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores. | 2021 | Details |
| A03215 | 34087329 | Adv Drug Deliv Rev | Role of extracellular vesicles in liver diseases and their therapeutic potential. | 2021 | Details |
| A03241 | 34074270 | BMC Gastroenterol | Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease. | 2021 | Details |
| A03334 | 34040322 | World J Gastroenterol | Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease. | 2021 | Details |
| A03365 | 34027337 | JHEP Rep | Defatting strategies in the current era of liver steatosis. | 2021 | Details |
| A03399 | 34016462 | Transplant Proc | Liver-Related and Cardiovascular Outcome of Patients Transplanted for Nonalcoholic Fatty Liver Disease: A European Single-Center Study. | 2021 | Details |
| A03430 | 34002452 | Obes Rev | Bariatric surgery and the liver-Mechanisms, benefits, and risks. | 2021 | Details |